Skip to main content
Erschienen in: Pediatric Radiology 9/2016

06.04.2016 | Original Article

Imaging features of kaposiform lymphangiomatosis

verfasst von: Pradeep Goyal, Ahmad I. Alomari, Harry P. Kozakewich, Cameron C. Trenor III, Antonio R. Perez-Atayde, Steven J. Fishman, Arin K. Greene, Raja Shaikh, Gulraiz Chaudry

Erschienen in: Pediatric Radiology | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Kaposiform lymphangiomatosis is a rare, aggressive lymphatic disorder. The imaging and presenting features of kaposiform lymphangiomatosis can overlap with those of central conducting lymphatic anomaly and generalized lymphatic anomaly.

Objective

To analyze the imaging findings of kaposiform lymphangiomatosis disorder and highlight features most suggestive of this diagnosis.

Materials and methods

We retrospectively identified and characterized 20 children and young adults with histopathological diagnosis of kaposiform lymphangiomatosis and radiologic imaging referred to the vascular anomalies center between 1995 and 2015.

Results

The median age at onset was 6.5 years (range 3 months to 27 years). The most common presenting features were respiratory compromise (dyspnea, cough, chest pain; 55.5%), swelling/mass (25%), bleeding (15%) and fracture (5%). The thoracic cavity was involved in all patients; all patients had mediastinal involvement followed by lung parenchymal disease (90%) and pleural (85%) and pericardial (50%) effusions. The most common extra-thoracic sites of disease were the retroperitoneum (80%), bone (60%), abdominal viscera (55%) and muscles (45%). There was characteristic enhancing and infiltrative soft-tissue thickening in the mediastinum and retroperitoneum extending along the lymphatic distribution.

Conclusion

Kaposiform lymphangiomatosis has overlapping imaging features with central conducting lymphatic anomaly and generalized lymphatic anomaly. Presence of mediastinal or retroperitoneal enhancing and infiltrative soft-tissue disease along the lymphatic distribution, hemorrhagic effusions and moderate thrombocytopenia (50–100,000/μl) should favor diagnosis of kaposiform lymphangiomatosis.
Literatur
1.
Zurück zum Zitat Croteau SE, Kozakewich HP, Perez-Atayde AR et al (2014) Kaposiform lymphangiomatosis: a distinct aggressive lymphatic anomaly. J Pediatr 164:383–388CrossRefPubMed Croteau SE, Kozakewich HP, Perez-Atayde AR et al (2014) Kaposiform lymphangiomatosis: a distinct aggressive lymphatic anomaly. J Pediatr 164:383–388CrossRefPubMed
2.
Zurück zum Zitat Safi F, Gupta A, Adams D et al (2014) Kaposiform lymphangiomatosis, a newly characterized vascular anomaly presenting with hemoptysis in an adult woman. Ann Am Thorac Soc 11:92–95CrossRefPubMed Safi F, Gupta A, Adams D et al (2014) Kaposiform lymphangiomatosis, a newly characterized vascular anomaly presenting with hemoptysis in an adult woman. Ann Am Thorac Soc 11:92–95CrossRefPubMed
3.
Zurück zum Zitat Detaille T, Joomye R, Barrea C et al (2010) Acute life-threatening presentation of unknown lymphatic malformation. Am J Emerg Med 28:1062.e1061–1063CrossRef Detaille T, Joomye R, Barrea C et al (2010) Acute life-threatening presentation of unknown lymphatic malformation. Am J Emerg Med 28:1062.e1061–1063CrossRef
4.
Zurück zum Zitat Debelenko L, Marler J, Perez-Atayde A et al (2004) Kaposiform lymphangiomatosis: an aggressive variant of lymphangiomatosis (LA). In: Laboratory investigation, vol. 84. Nature Publishing Group, New York, p 269 Debelenko L, Marler J, Perez-Atayde A et al (2004) Kaposiform lymphangiomatosis: an aggressive variant of lymphangiomatosis (LA). In: Laboratory investigation, vol. 84. Nature Publishing Group, New York, p 269
5.
6.
Zurück zum Zitat Fernandes VM, Fargo JH, Saini S et al (2015) Kaposiform lymphangiomatosis: unifying features of a heterogeneous disorder. Pediatr Blood Cancer 62:901–904CrossRefPubMed Fernandes VM, Fargo JH, Saini S et al (2015) Kaposiform lymphangiomatosis: unifying features of a heterogeneous disorder. Pediatr Blood Cancer 62:901–904CrossRefPubMed
7.
Zurück zum Zitat Enjolras O, Mulliken JB, Kozakewich HP (2013) Vascular tumors and tumors like lesions. In: Mulliken JB, Burrows PE, Fishman SJ (eds) Mulliken and Young’s vascular anomalies: hemangiomas and malformations, 2nd edn. Oxford University Press, New York, pp 259–326CrossRef Enjolras O, Mulliken JB, Kozakewich HP (2013) Vascular tumors and tumors like lesions. In: Mulliken JB, Burrows PE, Fishman SJ (eds) Mulliken and Young’s vascular anomalies: hemangiomas and malformations, 2nd edn. Oxford University Press, New York, pp 259–326CrossRef
8.
Zurück zum Zitat Fishman SJ (2013) Slow-flow vascular malformations. In: Mulliken JB, Burrows PE, Fishman SJ (eds) Mulliken & Young’s vascular anomalies: hemangiomas and malformations. Oxford University Press, New York Fishman SJ (2013) Slow-flow vascular malformations. In: Mulliken JB, Burrows PE, Fishman SJ (eds) Mulliken & Young’s vascular anomalies: hemangiomas and malformations. Oxford University Press, New York
9.
Zurück zum Zitat Tazelaar HD, Kerr D, Yousem SA et al (1993) Diffuse pulmonary lymphangiomatosis. Hum Pathol 24:1313–1322CrossRefPubMed Tazelaar HD, Kerr D, Yousem SA et al (1993) Diffuse pulmonary lymphangiomatosis. Hum Pathol 24:1313–1322CrossRefPubMed
10.
Zurück zum Zitat Lala S, Mulliken JB, Alomari AI et al (2013) Gorham-Stout disease and generalized lymphatic anomaly — clinical, radiologic, and histologic differentiation. Skeletal Radiol 42:917–924CrossRefPubMed Lala S, Mulliken JB, Alomari AI et al (2013) Gorham-Stout disease and generalized lymphatic anomaly — clinical, radiologic, and histologic differentiation. Skeletal Radiol 42:917–924CrossRefPubMed
11.
Zurück zum Zitat Hammill AM, Wentzel M, Gupta A et al (2011) Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer 57:1018–1024CrossRefPubMed Hammill AM, Wentzel M, Gupta A et al (2011) Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer 57:1018–1024CrossRefPubMed
12.
Zurück zum Zitat Reinglas J, Ramphal R, Bromwich M (2011) The successful management of diffuse lymphangiomatosis using sirolimus: a case report. Laryngoscope 121:1851–1854PubMed Reinglas J, Ramphal R, Bromwich M (2011) The successful management of diffuse lymphangiomatosis using sirolimus: a case report. Laryngoscope 121:1851–1854PubMed
13.
Zurück zum Zitat Lyons LL, North PE, Mac-Moune Lai F et al (2004) Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol 28:559–568CrossRefPubMed Lyons LL, North PE, Mac-Moune Lai F et al (2004) Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol 28:559–568CrossRefPubMed
14.
Zurück zum Zitat Zukerberg LR, Nickoloff BJ, Weiss SW (1993) Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol 17:321–328CrossRefPubMed Zukerberg LR, Nickoloff BJ, Weiss SW (1993) Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol 17:321–328CrossRefPubMed
15.
Zurück zum Zitat Croteau SE, Liang MG, Kozakewich HP et al (2013) Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals. J Pediatr 162:142–147CrossRefPubMed Croteau SE, Liang MG, Kozakewich HP et al (2013) Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals. J Pediatr 162:142–147CrossRefPubMed
16.
Zurück zum Zitat Enjolras O, Mulliken JB, Wassef M et al (2000) Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol 42:225–235CrossRefPubMed Enjolras O, Mulliken JB, Wassef M et al (2000) Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol 42:225–235CrossRefPubMed
17.
Zurück zum Zitat Haisley-Royster C, Enjolras O, Frieden IJ et al (2002) Kasabach-Merritt phenomenon: a retrospective study of treatment with vincristine. J Pediatr Hematol Oncol 24:459–462CrossRefPubMed Haisley-Royster C, Enjolras O, Frieden IJ et al (2002) Kasabach-Merritt phenomenon: a retrospective study of treatment with vincristine. J Pediatr Hematol Oncol 24:459–462CrossRefPubMed
Metadaten
Titel
Imaging features of kaposiform lymphangiomatosis
verfasst von
Pradeep Goyal
Ahmad I. Alomari
Harry P. Kozakewich
Cameron C. Trenor III
Antonio R. Perez-Atayde
Steven J. Fishman
Arin K. Greene
Raja Shaikh
Gulraiz Chaudry
Publikationsdatum
06.04.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Radiology / Ausgabe 9/2016
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-016-3611-1

Weitere Artikel der Ausgabe 9/2016

Pediatric Radiology 9/2016 Zur Ausgabe

Hermes

Hermes

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.